ID: ALA4214728

Max Phase: Preclinical

Molecular Formula: C17H16F3N7O2S

Molecular Weight: 439.42

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Nc1nc(N2CCN(C(=O)Nc3ccc(OC(F)(F)F)cc3)CC2)c2ncsc2n1

Standard InChI:  InChI=1S/C17H16F3N7O2S/c18-17(19,20)29-11-3-1-10(2-4-11)23-16(28)27-7-5-26(6-8-27)13-12-14(30-9-22-12)25-15(21)24-13/h1-4,9H,5-8H2,(H,23,28)(H2,21,24,25)

Standard InChI Key:  UVTJYKFIWBZRDV-UHFFFAOYSA-N

Associated Targets(Human)

PI4-kinase beta subunit 1593 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 439.42Molecular Weight (Monoisotopic): 439.1038AlogP: 2.92#Rotatable Bonds: 3
Polar Surface Area: 109.50Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.73CX Basic pKa: 4.35CX LogP: 3.52CX LogD: 3.52
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.65Np Likeness Score: -1.79

References

1. Reuberson J, Horsley H, Franklin RJ, Ford D, Neuss J, Brookings D, Huang Q, Vanderhoydonck B, Gao LJ, Jang MY, Herdewijn P, Ghawalkar A, Fallah-Arani F, Khan AR, Henshall J, Jairaj M, Malcolm S, Ward E, Shuttleworth L, Lin Y, Li S, Louat T, Waer M, Herman J, Payne A, Ceska T, Doyle C, Pitt W, Calmiano M, Augustin M, Steinbacher S, Lammens A, Allen R..  (2018)  Discovery of a Potent, Orally Bioavailable PI4KIIIβ Inhibitor (UCB9608) Able To Significantly Prolong Allogeneic Organ Engraftment in Vivo.,  61  (15): [PMID:29952567] [10.1021/acs.jmedchem.8b00521]

Source